Published in J Cardiovasc Magn Reson on August 02, 2012
MRI to Predict Rejection and Failure in Transplant and Cardiomyopathy Patients | NCT03822442
Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease. Sci Transl Med (2015) 2.43
Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review. J Cardiovasc Magn Reson (2016) 0.80
Imaging for assessment of sudden death risk: current role and future prospects. Europace (2016) 0.78
Role of Imaging Techniques for Diagnosis, Prognosis and Management of Heart Failure Patients: Cardiac Magnetic Resonance. Curr Heart Fail Rep (2015) 0.77
Cardiac sarcoidosis-state of the art review. Cardiovasc Diagn Ther (2016) 0.76
Review of Journal of Cardiovascular Magnetic Resonance 2012. J Cardiovasc Magn Reson (2013) 0.76
Evaluation of cardiac function by two-dimensional speckle tracking echocardiography in ulcerative colitis patients. Dig Dis Sci (2014) 0.75
Review of Journal of Cardiovascular Magnetic Resonance 2013. J Cardiovasc Magn Reson (2014) 0.75
What can cardiac magnetic resonance do for cardiologists in China? Pak J Med Sci (2013) 0.75
New cardiac magnetic resonance imaging modalities aid in the detection of myocardial fibrosis. Physiol Rep (2017) 0.75
Highlights of the 16th annual scientific sessions of the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson (2013) 0.75
Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med (2008) 19.76
Doxorubicin-induced cardiomyopathy. N Engl J Med (1998) 9.08
Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J (2001) 8.90
Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol (2009) 6.41
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34
Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med (2004) 6.27
Truncations of titin causing dilated cardiomyopathy. N Engl J Med (2012) 6.07
Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation (2005) 5.85
Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol (2008) 5.71
Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation (2010) 5.68
Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson (2008) 5.65
Left ventricular non-compaction: insights from cardiovascular magnetic resonance imaging. J Am Coll Cardiol (2005) 5.63
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol (2006) 5.58
Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol (2005) 5.50
Evaluation of techniques for the quantification of myocardial scar of differing etiology using cardiac magnetic resonance. JACC Cardiovasc Imaging (2011) 4.78
Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation (2003) 4.48
Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2006) 4.27
Clinical characteristics and cardiovascular magnetic resonance findings in stress (takotsubo) cardiomyopathy. JAMA (2011) 4.14
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J (2010) 4.13
Shortened Modified Look-Locker Inversion recovery (ShMOLLI) for clinical myocardial T1-mapping at 1.5 and 3 T within a 9 heartbeat breathhold. J Cardiovasc Magn Reson (2010) 4.10
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation (2006) 3.85
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy. Circulation (2008) 3.77
Direct T2 quantification of myocardial edema in acute ischemic injury. JACC Cardiovasc Imaging (2011) 3.77
Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging (2010) 3.50
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 3.50
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol (2008) 3.42
Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 3.20
Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation (2006) 3.20
Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J (2004) 3.19
Society for Cardiovascular Magnetic Resonance guidelines for reporting cardiovascular magnetic resonance examinations. J Cardiovasc Magn Reson (2009) 3.17
The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J (2007) 3.11
Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging (2010) 3.03
Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. J Am Coll Cardiol (2008) 2.99
Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson (2011) 2.96
Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol (2005) 2.93
Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation (2009) 2.88
Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging (2010) 2.86
Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2008) 2.85
Cardiovascular magnetic resonance in clinically suspected cardiac amyloidosis: noninvasive imaging compared to endomyocardial biopsy. J Am Coll Cardiol (2008) 2.82
Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. Radiology (1999) 2.76
Cardiac magnetic resonance with T2-weighted imaging improves detection of patients with acute coronary syndrome in the emergency department. Circulation (2008) 2.74
Myocardial T1 mapping: application to patients with acute and chronic myocardial infarction. Magn Reson Med (2007) 2.72
Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity. Eur J Heart Fail (2011) 2.71
Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol (2009) 2.71
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation (1997) 2.65
Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol (2008) 2.59
Left ventricular hypertrophy in aortic valve stenosis: preventive or promotive of systolic dysfunction and heart failure? Eur Heart J (2005) 2.42
Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol (2010) 2.38
On T2* magnetic resonance and cardiac iron. Circulation (2011) 2.33
Detection of myocardial damage in patients with sarcoidosis. Circulation (2009) 2.31
Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging. J Am Coll Cardiol (2005) 2.30
Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart (2004) 2.22
Impact of the revision of arrhythmogenic right ventricular cardiomyopathy/dysplasia task force criteria on its prevalence by CMR criteria. JACC Cardiovasc Imaging (2011) 2.22
Nuclear magnetic resonance imaging of acute myocardial infarction in dogs: alterations in magnetic relaxation times. Am J Cardiol (1983) 2.21
Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging. Eur Heart J (2008) 2.18
Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation (2007) 2.14
Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension (2002) 2.11
Cardiac magnetic resonance monitors reversible and irreversible myocardial injury in myocarditis. JACC Cardiovasc Imaging (2009) 2.08
Measurement of the gadopentetate dimeglumine partition coefficient in human myocardium in vivo: normal distribution and elevation in acute and chronic infarction. Radiology (2001) 2.04
Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson (2008) 2.01
Immunohistological basis of the late gadolinium enhancement phenomenon in tako-tsubo cardiomyopathy. Eur Heart J (2009) 1.90
Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards? J Am Coll Cardiol (2003) 1.88
Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro. Int J Cardiovasc Imaging (2007) 1.86
Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium-DTPA-enhanced magnetic resonance imaging. Am J Med (2001) 1.85
T2-weighted cardiovascular magnetic resonance in acute cardiac disease. J Cardiovasc Magn Reson (2011) 1.79
ACUT2E TSE-SSFP: a hybrid method for T2-weighted imaging of edema in the heart. Magn Reson Med (2008) 1.75
Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation (2011) 1.74
T1 mapping of the gadolinium-enhanced myocardium: adjustment for factors affecting interpatient comparison. Magn Reson Med (2010) 1.68
Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol (2006) 1.67
Myocardial salvage: retrospection, resolution, and radio waves. Circulation (2006) 1.64
Prevalence of different gadolinium enhancement patterns in patients after heart transplantation. J Am Coll Cardiol (2008) 1.63
Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging (2009) 1.61
Myocardial edema--a new clinical entity? Nat Rev Cardiol (2010) 1.59
Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy. Circ Heart Fail (2008) 1.58
Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions. JACC Cardiovasc Imaging (2010) 1.56
Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation (2007) 1.54
Myocardial tagging by cardiovascular magnetic resonance: evolution of techniques--pulse sequences, analysis algorithms, and applications. J Cardiovasc Magn Reson (2011) 1.53
Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar. Cardiovasc Ultrasound (2009) 1.50
Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation (2009) 1.49
Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol (2009) 1.48
Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol (2009) 1.44
Myocardial delayed enhancement by magnetic resonance imaging in patients with Chagas' disease: a marker of disease severity. J Am Coll Cardiol (2005) 1.43
Myocardial edema is a feature of Tako-Tsubo cardiomyopathy and is related to the severity of systolic dysfunction: insights from T2-weighted cardiovascular magnetic resonance. Int J Cardiol (2007) 1.41
Cardiovascular magnetic resonance myocardial feature tracking detects quantitative wall motion during dobutamine stress. J Cardiovasc Magn Reson (2011) 1.40
Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy. Transpl Int (2001) 1.37
Usefulness of cardiac magnetic resonance in assessing the risk of ventricular arrhythmias and sudden death in patients with hypertrophic cardiomyopathy. Eur Heart J (2009) 1.35
Diagnostic and prognostic utility of cardiovascular magnetic resonance imaging in light-chain cardiac amyloidosis. Am J Cardiol (2008) 1.31
Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence. J Am Coll Cardiol (2001) 1.27
Quantification of regional myocardial oxygenation by magnetic resonance imaging: validation with positron emission tomography. Circ Cardiovasc Imaging (2009) 1.27
Using magnetic resonance imaging to characterize recent myocardial injury: utility in acute coronary syndrome and other clinical scenarios. Circulation (2008) 1.21
Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J (2006) 1.14
Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy. Eur J Heart Fail (2010) 1.14
The future of real-time cardiac magnetic resonance imaging. Curr Cardiol Rep (2005) 1.14
The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson (2006) 1.12
Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol (2006) 5.58
Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. JAMA (2013) 5.19
Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial. JAMA (2013) 4.17
Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol (2010) 3.50
Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol (2008) 3.42
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med (2016) 3.40
The role of cardiovascular magnetic resonance in patients presenting with chest pain, raised troponin, and unobstructed coronary arteries. Eur Heart J (2007) 3.11
Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol (2011) 2.66
Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study. Am J Respir Crit Care Med (2005) 2.49
Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J (2006) 2.35
Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson (2008) 2.01
Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Eur Radiol (2005) 1.99
Spatio-temporal free-form registration of cardiac MR image sequences. Med Image Anal (2005) 1.81
Role of cardiovascular magnetic resonance as a gatekeeper to invasive coronary angiography in patients presenting with heart failure of unknown etiology. Circulation (2011) 1.74
Segmentation of 4D cardiac MR images using a probabilistic atlas and the EM algorithm. Med Image Anal (2004) 1.67
Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype. J Am Coll Cardiol (2006) 1.67
Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass. Nat Genet (2008) 1.67
The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol (2009) 1.66
Prognostic role of CMR in patients presenting with ventricular arrhythmias. JACC Cardiovasc Imaging (2013) 1.62
Prevalence of inferobasal myocardial crypts among patients referred for cardiovascular magnetic resonance. Circ Cardiovasc Imaging (2014) 1.61
Myocardial T2* measurements in iron-overloaded thalassemia: An in vivo study to investigate optimal methods of quantification. Magn Reson Med (2008) 1.60
Assessing normal pulse wave velocity in the proximal pulmonary arteries using transit time: a feasibility, repeatability, and observer reproducibility study by cardiovascular magnetic resonance. J Magn Reson Imaging (2007) 1.50
Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance. Arthritis Rheum (2009) 1.48
New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions? JACC Cardiovasc Interv (2010) 1.46
Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 1.46
Seeking optimal relation between oxygen saturation and hemoglobin concentration in adults with cyanosis from congenital heart disease. Am J Cardiol (2011) 1.44
Black-blood T2* technique for myocardial iron measurement in thalassemia. J Magn Reson Imaging (2007) 1.41
Aspirin use in heart failure: is low-dose therapy associated with mortality and morbidity benefits in a large community population? Circ Heart Fail (2014) 1.40
Images in cardiovascular medicine. Occult anomalous pulmonary venous drainage: the clinical value of cardiac magnetic resonance imaging. Circulation (2002) 1.39
Myocardial T*2 measurement in iron-overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification. Magn Reson Med (2008) 1.38
Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol (2011) 1.37
Evidence for Marfan cardiomyopathy. Eur J Heart Fail (2010) 1.35
Construction of a statistical model for cardiac motion analysis using nonrigid image registration. Inf Process Med Imaging (2003) 1.35
Role of magnetic resonance angiography in the diagnosis of major aortopulmonary collateral arteries and partial anomalous pulmonary venous drainage. Circulation (2004) 1.33
Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. J Cardiovasc Med (Hagerstown) (2007) 1.26
Volume-selective 3D turbo spin echo imaging for vascular wall imaging and distensibility measurement. J Magn Reson Imaging (2003) 1.25
Cardiac MRI and pulmonary MR angiography of sinus venosus defect and partial anomalous pulmonary venous connection in cause of right undiagnosed ventricular enlargement. AJR Am J Roentgenol (2009) 1.25
Improved turbo spin-echo imaging of the heart with motion-tracking. J Magn Reson Imaging (2006) 1.25
Analysis of 3-D myocardial motion in tagged MR images using nonrigid image registration. IEEE Trans Med Imaging (2004) 1.24
The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation (2013) 1.19
Simvastatin as a treatment for pulmonary hypertension trial. Am J Respir Crit Care Med (2010) 1.15
Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2012) 1.15
Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2008) 1.15
In vivo cardiovascular magnetic resonance diffusion tensor imaging shows evidence of abnormal myocardial laminar orientations and mobility in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson (2014) 1.14
Cardiovascular magnetic resonance artefacts. J Cardiovasc Magn Reson (2013) 1.13
Clinical and haemodynamic effects of sildenafil in pulmonary hypertension: acute and mid-term effects. Eur Heart J (2004) 1.13
Value of cardiovascular magnetic resonance for determining cardiac involvement in systemic amyloidosis. Eur Heart J (2006) 1.07
3D volume-selective turbo spin echo for carotid artery wall imaging with navigator detection of swallowing. J Magn Reson Imaging (2005) 1.06
Reference right atrial dimensions and volume estimation by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2013) 1.04
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol (2012) 1.03
Prognostic importance of late gadolinium enhancement cardiovascular magnetic resonance in cardiomyopathy. Heart (2011) 1.03
Reproducibility of in-vivo diffusion tensor cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson (2012) 1.02
Prevalence of associated cardiovascular abnormalities in 500 patients with aortic coarctation referred for cardiovascular magnetic resonance imaging to a tertiary center. Pediatr Cardiol (2011) 1.01
Acute myocardial infarction in the presence of normal coronaries and the absence of risk factors in a young, lifelong regular exerciser. BMJ Case Rep (2009) 1.01
Measuring the heart in pulmonary arterial hypertension (PAH): implications for trial study size. J Magn Reson Imaging (2010) 1.00
Cardiovascular magnetic resonance in the evaluation of heart failure. Heart (2007) 1.00
Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy. Eur J Heart Fail (2013) 1.00
Images in cardiovascular medicine. Myocardial fibrosis in glycogen storage disease type III. Circulation (2003) 0.99
Troponin release following endurance exercise: is inflammation the cause? a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2010) 0.97
Optimization of the arterial input function for myocardial perfusion cardiovascular magnetic resonance. J Magn Reson Imaging (2005) 0.94
On using T2 to assess extrinsic magnetic field inhomogeneity effects on T2* measurements in myocardial siderosis in thalassemia. Magn Reson Med (2009) 0.93
Understanding late gadolinium enhancement in pulmonary hypertension. Circ Cardiovasc Imaging (2010) 0.92
Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. J Cardiovasc Magn Reson (2011) 0.92
Coronary microvascular ischemia in hypertrophic cardiomyopathy - a pixel-wise quantitative cardiovascular magnetic resonance perfusion study. J Cardiovasc Magn Reson (2014) 0.92
T₁ mapping detects pharmacological retardation of diffuse cardiac fibrosis in mouse pressure-overload hypertrophy. Circ Cardiovasc Imaging (2014) 0.91
Prognostic value of cardiovascular magnetic resonance in patients with suspected arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol (2013) 0.91
Cardiovascular magnetic resonance in Marfan syndrome. J Cardiovasc Magn Reson (2013) 0.91
Images in cardiovascular medicine: Magnetic resonance angiography of a congenitally interrupted aortic arch. Circulation (2002) 0.90
Cardiovascular magnetic resonance in pulmonary hypertension. J Cardiovasc Magn Reson (2012) 0.90
Complementary role of echocardiography and cardiac magnetic resonance in the non-invasive evaluation of suspected arrhythmogenic right ventricular cardiomyopathy. J Interv Card Electrophysiol (2004) 0.90
Markers of left ventricular decompensation in aortic stenosis. Expert Rev Cardiovasc Ther (2014) 0.90
Follow up in a case of cardiac contusion using cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2007) 0.88
Multidsciplinary heart failure management and end of life care. Curr Opin Support Palliat Care (2011) 0.86
Elimination of residual blood flow-related signal in 3D volume-selective TSE arterial wall imaging using velocity-sensitive phase reconstruction. J Magn Reson Imaging (2006) 0.86
A depression in left ventricular diastolic filling following prolonged strenuous exercise is associated with changes in left atrial mechanics. J Am Soc Echocardiogr (2010) 0.86
Interstudy reproducibility of three-dimensional volume-selective fast spin echo magnetic resonance for quantifying carotid artery wall volume. J Magn Reson Imaging (2005) 0.85
Aortic papillary fibroelastoma as an unusual cause of angina: insights from multimodality imaging. Circ Cardiovasc Imaging (2011) 0.85
Comparison between three-dimensional volume-selective turbo spin-echo imaging and two-dimensional ultrasound for assessing carotid artery structure and function. J Magn Reson Imaging (2005) 0.85
Integrated morphologic and functional assessment of the aortic root after different tissue valve root replacement procedures. J Thorac Cardiovasc Surg (2012) 0.85
Comparison of spiral and FLASH phase velocity mapping, with and without breath-holding, for the assessment of left and right coronary artery blood flow velocity. J Magn Reson Imaging (2004) 0.84
Tubercular myocarditis presenting with ventricular tachycardia. Nat Clin Pract Cardiovasc Med (2008) 0.83
Can individualized weight monitoring using the HeartPhone algorithm improve sensitivity for clinical deterioration of heart failure? Eur J Heart Fail (2012) 0.82
Cardiovascular magnetic resonance in systemic hypertension. J Cardiovasc Magn Reson (2012) 0.82
Myocardial fibrosis in thalassaemia: recalling the past or telling the future? Heart (2009) 0.82
Imaging myocardial carcinoid with T2-STIR CMR. J Cardiovasc Magn Reson (2008) 0.82
Angiosarcoma of the right atrium: a diagnostic dilemma. Int J Cardiol (2005) 0.81
Comparison of hybrid echo-planar imaging and FLASH myocardial perfusion cardiovascular MR imaging. Radiology (2005) 0.81
Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement. Interact Cardiovasc Thorac Surg (2012) 0.81
Cardiac pseudotumor: tissue characterization by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2003) 0.81
Breath-hold signal-loss sequence for the qualitative assessment of flow disturbances in cardiovascular MR. J Magn Reson Imaging (2003) 0.80